Background: Granular cell tumors are rare tumors most often located in the oral cavity, skin or subcutaneous tissue. The occurrence of this tumor in the biliary tree is extremely rare. Methods: Two patients are described presenting with biliary obstruction due to a tumor at the hepatic duct confluence. One patient is a 38-year-old white male with concomitant cutaneous granular cell tumors, and the other a 50-year-old white female. Results: Hilar excision was performed in both patients. Histopathology of the tumors revealed a proliferation of cells with granular cytoplasm, diagnosed as granular cell tumor. Conclusion: At preoperative examination, hilar granular cell tumors are difficult to differentiate from cholangiocarcinoma, sclerosing cholangitis or more common benign biliary tumors. Treatment consists of surgical excision after which prognosis is favorable.

Keywords:
Granular cell tumor, Klatskin tumor, Endoscopic retrograde cholangiopancreatography, Resection, bile duct
1.
Butterly LF, Schapiro RH, LaMuraglia AE, Warshaw AL: Biliary granular cell tumor: A little-known curable bile duct neoplasm of young people. Surgery 1988;103:329–334.
2.
Abrikossoff A: Über Myome ausgehend von der quergestreiften willkürlichen Muskulatur. Virchows Arch [A] 1926;260:215–233.
3.
Coggins RP: Granular cell myoblastoma of the common bile duct. Arch Pathol 1952;54:398–402.
4.
Bangle R Jr: An early granular cell myoblastoma confined within a small peripheral myelinated nerve. Cancer 1953;6:790–793.
5.
Fisher ER, Wechsler A: Granular cell myoblastoma – A misnomer. Electron microscopic and histochemical evidence concerning its Schwann cell derivation and nature (granular cell Schwannoma). Cancer 1962;15:936–944.
6.
Sobel HJ, Chung J: Granular cells and granular cell lesions. Arch Pathol Lab Med 1964;77:132–141.
7.
Garancis JC, Komorowski RA, Kuzma JF: Granular cell myoblastoma. Cancer 1970;25:542–550.
8.
Sobel HJ, Marquet E, Arvin E, Schwarz R: Granular cell myoblastoma. Am J Pathol 1971;65:59–78.
9.
Sobel HJ, Schwarz R, Marquet E: Light and electron microscope study of the origin of granular-cell myoblastoma. J Pathol 1973;109:101–111.
10.
Li Volsi AV, Perzin KH, Bladdler EM, et al: Granular cell tumors of the biliary tract. Arch Pathol 1973;95:13–17.
11.
Assor D: Granular cell myoblastoma involving the common bile duct. Am J Surg 1979;137:673–675.
12.
Orenstein HH, Brenner LH, Nay HR: Granular cell myoblastoma of the extrahepatic biliary system. Am J Surg 1984;147:827–831.
13.
Manstein ME, McBrearty FX, Pellechia PE, Paskin DL: Granular cell tumor of the common bile duct. Dig Dis Sci 1981;26:938–942.
14.
Mueller PR, van Sonnenberg E, Ferrucci JT: Percutaneous biliary drainage: Technical and catheter related problems in 200 procedures. Am J Radiol 1982;138:17–23.
15.
Dooley JS, Dick R, Irving D, Olney J, Sherlock S: Relief of bile duct obstruction by the percutaneous transhepatic insertion of an endoprosthesis. Clin Radiol 1981;32:163–172.
16.
Burcharth F, Efsen F, Christiansen LA: Nonsurgical internal biliary drainage by endoprosthesis. Surg Gynecol Obstet 1981;153:857–860.
17.
Klima M, Peters J: Malignant granular cell tumor. Arch Pathol Lab Med 1987;111:170–173.
18.
Cadotte M: Malignant granular cell myoblastoma. Cancer 1974;33:1417–1422.
19.
Dursi JF, Hirschl S, Gomez R: Granular cell myoblastoma of the common bile duct: Report of a case and review of the literature. Rev Surg 1975;32:305–310.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.